Peroxisome proliferator-activated receptor γ and retinoic acid receptor synergistically up-regulate the tumor suppressor PTEN in human promyeloid leukemia cells

International Journal of Hematology

Volumn 85, Issue 3, 2007, Pages 231-237

  Lee, Young Rae ^a   Yu, Hong Nu ^a   Noh, Eun Mi ^a   Kim, Jong Suk ^a   Song, Eun Kyung ^a   Han, Myung Kwan ^a   Kim, Byeong Soo ^b   Lee, Sung Ho ^b   Park, Jinny ^c  

^a Chonbuk National University Medical School   (South Korea)

^b Kongju National University   (South Korea)

^c Gachon University College of Medicine   (South Korea)

Author keywords

HL 60; PPAR ; PTEN; RAR

Indexed keywords

ADENOVIRUS VECTOR; CIGLITAZONE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL STRAIN HL 60; CELL THERAPY; GENE OVEREXPRESSION; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELOID LEUKEMIA; RECEPTOR UPREGULATION;

CELL CYCLE; HL-60 CELLS; HUMANS; PPAR GAMMA; PTEN PHOSPHOHYDROLASE; RECEPTORS, RETINOIC ACID; THIAZOLIDINEDIONES; TRETINOIN; UP-REGULATION;

EID: 34247554294     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.A30615     Document Type: Article

References (24)

1. Barbui T, Finazzi G, Falanga A. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood. 1998;91:3093-3102.
2. Rosen ED, Spiegelman BM. PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem. 2001;276:37731-37734.
3. Konopleva M, Andreeff M. Role of peroxisome proliferator-activated receptor-γ in hematologic malignancies. Curr Opin Hematol. 2002;9:294-302.
4. Koeffler HP. Peroxisome proliferator-activated receptor γ and cancers. Clin Cancer Res. 2003;9:1-9.
5. Szanto A, Nagy L. Retinoids potentiate peroxisome proliferator-activated receptor y action in differentiation, gene expression, and lipid metabolic processes in developing myeloid cells. Mol Pharmacol. 2005;67:1935-1943.
6. Yasugi E, Horiuchi A, Uemura I, et al. Peroxisome proliferator-activated receptor y ligands stimulate myeloid differentiation and lipogenesis in human leukemia NB4 cells. Dev Growth Differ. 2006;48:177-188.
7. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA. 1980;77:2936-2940.
8. Hirase N, Yanase T, Mu Y, et al. Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60. Oncology. 1999;57(suppl 2):17-26.
9. Myers MP, Pass I, Batty IH, et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A. 1998;95:13513-13518.
10. Wen S, Stolarov J, Myers MP, et al. PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci U S A. 2001;98:4622-4627.
11. Kim JS, Peng X, De PK, Geahlen RL, Durden DL. PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac. Blood. 2002;99:694-697.
12. Patel L, Pass I, Coxon P, Downes CP, Smith SA, Macphee CH. Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN. Curr Biol. 2001;11:764-768.
13. Kim KY, Kim SS, Cheon HG. Differential anti-proliferative actions of peroxisome proliferator-activated receptor-γ agonists in MCF-7 breast cancer cells. Biochem Pharmacol. 2006;72:530-540.
14. Kwak YG, Song CH, Yi HK, et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest. 2003;111:1083-1092.
15. Hwang PH, Yi HK, Kim DS, Nam SY, Kim JS, Lee DY. Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene. Cancer Lett. 2001;172:83-91.
16. 1 expression. Leukemia. 2003;17:2157-2167.
17. Seminario MC, Precht P, Wersto RP, Gorospe M, Wange RL. PTEN expression in PTEN-null leukaemic T cell lines leads to reduced proliferation via slowed cell cycle progression. Oncogene. 2003;22:8195-8204.
18. 1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-KB and AP-1 in vascular smooth muscle cells. Arch Biochem Biophys. 2004;421:267-276.
19. 1 arrest followed by cell death. Cancer Res. 1999;59:5808-5814.
20. Weng LP, Gimm O, Kum JB, et al. Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. Hum Mol Genet. 2001;10:251-258.
21. Davies MA, Lu Y, Sano T, et al. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res. 1998;58:5285-5290.
22. Davies MA, Koul D, Dhesi H, et al. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res. 1999;59:2551-2556.
23. 3, that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood. 2001;97:2427-2433.
24. Lee YR, Shim HJ, Yu HN, et al. Dimethylsulfoxide induces upregulation of tumor suppressor protein PTEN through nuclear factor-κB activation in HL-60 cells. Leuk Res. 2005;29:401-405.